Protalix BioTherapeutics
PLX
#8918
Rank
A$0.27 B
Marketcap
A$3.39
Share price
0.00%
Change (1 day)
39.73%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): A$30.12 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$76.38 Million. In 2025 the company made an earning of -A$6.09 Million a decrease over its 2024 earnings that were of A$7.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$30.12 M-594.98%
2025 -A$6.09 Million-181.6%
2024 A$7.45 M-55.62%
2023 A$16.8 M-199.05%
2022 -A$16.97 Million-40.38%
2021 -A$28.47 Million-732.31%
2020 A$4.5 M-130.53%
2019 -A$14.75 Million189.85%
2018 -A$5.09 Million-95.29%
2017 -A$0.11 Billion308.12%
2016 -A$26.47 Million-32.37%
2015 -A$39.14 Million10.11%
2014 -A$35.55 Million-7.59%
2013 -A$38.47 Million
2011 -A$44.54 Million-19.39%
2010 -A$55.26 Million20.87%
2009 -A$45.72 Million32.26%
2008 -A$34.57 Million-5.46%
2007 -A$36.56 Million
2004 -A$0.24 Million12.35%
2003 -A$0.22 Million-11.1%
2002 -A$0.24 Million-57.03%
2001 -A$0.56 Million1.03%
2000 -A$0.55 Million-53.22%
1999 -A$1.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.14 B 50,808.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.14 B 3,739.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.27 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.24 B 10,816.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel